79903-04-1

Basic information

• Product Name: N-butyl-2-nitrobenzamide
• Synonyms: N-butyl-2-nitrobenzamide
• CAS NO: 79903-04-1
• Molecular Weight: 222.244
• Mol File: 79903-04-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: N-butyl-2-nitrobenzamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-butyl-2-nitrobenzamide(79903-04-1)
• EPA Substance Registry System: N-butyl-2-nitrobenzamide(79903-04-1)

Safety Data

• Hazardous Substances Data: 79903-04-1(Hazardous Substances Data)

Upstream product

• 552-16-9 ortho-nitrobenzoic acid 
• 109-73-9 N-butylamine 
• 609-73-4 o-nitroiodobenzene 
• 13939-06-5 molybdenum hexacarbonyl 
• 31204-05-4 2-nitrobenzoic acid 4-nitrophenyl ester 
• 610-14-0 2-nitrobenzyl chloride 

Downstream Products

• 6944-59-8 3-n-butylquinazoline-2,4-(1H,3H)-dione 
• 89438-55-1 2-butyl-2,3-dihydro-1H-indazol-3-one 
• 1904-58-1 anthranilic acid hydrazide 
• 10494-82-3 2-amino-N-butylbenzamide 

Relevant articles and documents

A B2(OH)4-Mediated Synthesis of 2-Substituted Indazolone and Its Application in a DNA-Encoded Library

Indazolone cores are among the most common structural components in medicinal chemistry and can be found in many biologically active molecules. In this report, a mild and efficient approach to 2-substituted indazolones via B2(OH)4-mediated reductive N-N b

QUINAZOLINONE AND FUSED PYRIMIDINONE COMPOUNDS AND THEIR USE IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS

This invention is directed to compounds of formula (I): wherein (A), n, R1, R2 and R3 are as defined herein, as a stereoisomer, enantiomer, tautomer thereof or mixtures thereof; or a pharmaceutically acceptable salt, solvate or prodrug thereof, for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain.